Protalix Biotherapeutics' Series C Round

Protalix Biotherapeutics raised a round of funding on August 18, 2005.

Protalix Biotherapeutics is a biopharmaceutical company that specializes in the manufacture of recombinant therapeutic proteins through its ProCellEx plant cell-based protein expression system. Using …

Articles about Protalix Biotherapeutics' Series C Round: